Enzo Biochem Inc. (ENZ)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Elazar Rabbani
Employees:
460
60 EXECUTIVE BLVD, FARMINGDALE, NY 11735
5167555500

Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.

Data derived from most recent annual or quarterly report
Market Cap 115.928 Million Shares Outstanding48.709 Million Avg 30-day Volume 69.964 Thousand
P/E Ratio0.0054 Dividend Yield0.0 EPS0.16
Price to Revenue0.0013 Debt to Equity0.0656 EBITDA31.007 Million
Price to Book Value0.0024 Operating Margin-4.4595 Enterprise Value-29.213 Million
Current Ratio2.551 EPS Growth0 Quick Ratio1.872
1 Yr BETA 0.5919 52-week High/Low 4.15 / 2.23 Profit Margin0.2539
Operating Cash Flow Growth62.0364 Altman Z-Score-1.1506 Free Cash Flow to Firm -12.346 Million
View SEC Filings from ENZ instead.

View recent insider trading info

Funds Holding ENZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ENZ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TAGLIAFERRI MARY

  • Director
116,164 2022-04-27 1

RADOFF BRADLEY LOUIS

  • Director
4,367,163 2022-04-27 3

WALTERS IAN B.

  • Director
116,164 2022-04-27 1

BENCH DAVID CHIEF FINANCIAL OFFICER

  • Officer
150,418 2022-04-13 3

ERFANIAN HAMID CHIEF EXECUTIVE OFFICER

  • Officer
970,000 2022-04-13 3

CANNON KARA CHIEF OPERATING OFFICER

  • Officer
22,614 2022-03-24 2

HARBERT MANAGEMENT CORP

HARBERT DISCOVERY FUND, LP

HARBERT DISCOVERY FUND GP, LLC

HARBERT DISCOVERY CO-INVESTMENT FUND I, LP

HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC

HARBERT FUND ADVISORS, INC.

BRYANT JOHN F.

LUCAS KENAN

HARBERT RAYMOND J

  • 10% Owner
5,175,913 2021-03-15 0

WEINER BARRY W PRESIDENT AND TREASURER

  • Officer
1,657,499 2021-01-11 0

RABBANI ELAZAR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
2,262,208 2021-01-11 0

PERLYSKY DOV

  • Director
0 2021-01-11 0

FISCHER REBECCA J.

  • Director
0 2021-01-11 0

CLEMENS PETER J IV

  • Director
0 2020-04-23 0

BLANK FABIAN

  • Director
0 2020-04-23 0

BORTZ GREGORY M.

  • Director
93,699 2019-01-14 0

O'BRIEN JAMES MICHAEL EVP OF FINANCE

  • Officer
0 2019-01-03 0

HANNA BRUCE A.

  • Director
0 2019-01-03 0

GOLDBERG DAVID C VP CORPDEV IGM ENZ CLIN LABS

  • Officer
0 2016-03-14 0

KASTEN BERNARD L

  • Director
0 2016-01-06 0

BASS HERBERT B VP OF FINANCE

  • Officer
0 2014-01-17 0

CRESCENZO ANDREW R. SENIOR VP OF FINANCE

  • Officer
0 2014-01-17 0

WHITELEY ANDREW P COO, ENZO LIFE SCIENCES, INC.

  • Officer
0 2014-01-17 0

KENT STEPHEN B H

  • Director
0 2012-01-26 0

BALEZENTIS CARL W PRES., ENZO LIFE SCIENCES

  • Officer
25,950 2010-12-15 0

GERSON IRWIN

  • Director
0 2010-03-04 0

LAZAR MELVIN F

  • Director
0 2010-03-04 0

KRENITSKY KEVIN PRESIDENT, ENZO CLINICAL LABS

  • Officer
17,600 2010-01-29 0

RABBANI SHAHRAM K TREASURER, SECRETARY

  • Officer
  • Director
1,539,392 2009-07-01 0

FISCHETTE CHRISTINE PRES., ENZO THERAPEUTICS, INC.

  • Officer
11,500 2009-01-22 0

SIAS JOHN B

  • Director
173,087 2008-09-26 0

KELKER NORMAN E SENIOR VICE PRESIDENT

  • Officer
110,855 2008-09-23 0

DELUCCA JOHN

  • Director
18,589 2008-01-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RADOFF BRADLEY LOUIS - Director

2022-04-29 16:40:33 -0400 2022-04-27 A 39,063 a 3,937,163 direct -2.0408 -2.0408 1.6327 4 -2.0408 2

TAGLIAFERRI MARY - Director

2022-04-29 16:44:42 -0400 2022-04-27 A 39,063 a 39,063 direct -2.0408 -2.0408 1.6327 4 -2.0408 2

WALTERS IAN B. - Director

2022-04-29 16:35:44 -0400 2022-04-27 A 39,063 a 39,063 direct -2.0408 -2.0408 1.6327 4 -2.0408 2

RADOFF BRADLEY LOUIS - Director by the radoff family foundation

2022-04-15 10:23:02 -0400 2022-04-14 A 30,000 $2.91 a 430,000 indirect 1.4035 -3.5088 1.7544 3 -3.5088 6

BENCH DAVID - Officer CHIEF FINANCIAL OFFICER by trust (psp)

2022-04-14 19:58:17 -0400 2022-04-14 A 1,620 $2.90 a 2,500 indirect 1.4035 -3.5088 1.7544 3 -3.5088 6

BENCH DAVID - Officer CHIEF FINANCIAL OFFICER by trust (psp)

2022-04-14 19:58:17 -0400 2022-04-13 A 880 $2.90 a 880 indirect 1.4035 -3.5088 1.7544 3 -3.5088 6

ERFANIAN HAMID - Officer CHIEF EXECUTIVE OFFICER

2022-04-14 13:52:56 -0400 2022-04-13 A 10,000 $2.90 a 270,000 direct -1.0417 -2.7778 0.6944 4 -2.7778 6

BENCH DAVID - Officer CFO, SVP, TREASURER AND CS

2022-03-28 17:31:00 -0400 2022-03-24 A 87,500 a 87,500 direct

CANNON KARA - Officer CHIEF OPERATING OFFICER

2022-03-28 18:03:22 -0400 2022-03-24 A 87,500 a 87,500 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ENZO BIOCHEM INC ENZ 2022-05-17 21:15:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 20:45:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 20:15:05 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 19:45:04 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 19:15:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 18:45:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 18:15:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 17:45:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 17:15:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 16:45:04 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 16:15:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 15:45:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 15:15:03 UTC -0.0589 0.8789 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 14:45:03 UTC -0.0473 0.8673 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 14:15:03 UTC -0.0473 0.8673 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 13:45:03 UTC -0.0473 0.8673 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 13:15:03 UTC -0.0473 0.8673 1200000
ENZO BIOCHEM INC ENZ 2022-05-17 12:45:03 UTC -0.0473 0.8673 1200000
ENZO BIOCHEM INC ENZ 2022-05-16 22:15:03 UTC -0.0473 0.8673 1100000
ENZO BIOCHEM INC ENZ 2022-05-16 21:45:04 UTC -0.0473 0.8673 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments